Latest filing published 20 Nov 2017 for X4 Pharmaceuticals, Inc.
Insider track record
No signal scores available.
Anna-Maria & Stephen Kellen Foundation, Inc.: trading record in brief
Anna-Maria & Stephen Kellen Foundation, Inc. discloses dealings in X4 Pharmaceuticals, Inc to SEC (Form 4). The record holds 2 filings, all for trades on 20 November 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 20 November 2017 with a transaction in X4 Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anna-Maria & Stephen Kellen Foundation, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,819 sharesCommon StockSEC:0000899243-17-027015:0
- 98,562 sharesCommon StockSEC:0000899243-17-027015:1
2 of 2 declarations